• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝胰岛素清除的决定因素 - 孟德尔随机化研究的结果。

Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.

机构信息

Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital of Tübingen, Tübingen, Germany; Institute of Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.

Institute of Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Section on Experimental Radiology, Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.

出版信息

Metabolism. 2021 Jun;119:154776. doi: 10.1016/j.metabol.2021.154776. Epub 2021 Apr 20.

DOI:10.1016/j.metabol.2021.154776
PMID:33862045
Abstract

AIMS/HYPOTHESIS: Besides insulin resistance, type 2 diabetes associates with decreased hepatic insulin clearance (HIC). We now tested for causal relationship of HIC to liver fat accumulation or features of the metabolic syndrome.

METHODS

HIC was derived from oral glucose tolerance tests with the "Oral C-peptide and Insulin Minimal Models" (n = 3311). Liver fat was quantified by magnetic resonance spectroscopy (n = 1211). Mendelian Randomization was performed using established single nucleotide polymorphisms (SNPs; 115 for liver fat, 155 alanine-aminotransferase, 37 insulin sensitivity, 37 insulin secretion, 72 fasting insulin, 5285 BMI, 163 visceral fat, 270 waist circumference, 442 triglycerides, 620 HDL-Cholesterol, 193 C-reactive protein, 53 lipodystrophy-like phenotypes).

RESULTS

HIC associated inversely with liver fat (p < 0.003) and insulin sensitivity (p < 0.0001). Both liver fat and HIC were independently associated with insulin sensitivity (p < 0.0001). Neither liver fat nor alanine-aminotransferase were causally linked to HIC, as indicated by Mendelian Randomization (N = 1054, N = 2254; N = 1985, N = 2251). BMI-related SNPs were causally associated with HIC (N = 2772, N = 2259, p < 0.001) but not waist circumference-SNPs (N = 2751, N = 2280). Genetically determined insulin sensitivity was not causally related to HIC (N = 2752, N = 2286). C-reactive protein and HDL were causally associated with HIC, with higher C-reactive protein and lower HDL leading to higher HIC (N = 2660, N = 2240; N = 2694, N = 2275).

CONCLUSIONS

This Mendelian Randomization analysis does not support a causal link between hepatic steatosis and HIC. Other components of the metabolic syndrome seem to compensate peripheral hyperinsulinemia by increasing hepatic insulin extraction.

摘要

目的/假设:除了胰岛素抵抗,2 型糖尿病还与肝胰岛素清除率(HIC)降低有关。我们现在测试了 HIC 与肝脂肪堆积或代谢综合征特征的因果关系。

方法

通过“口服 C 肽和胰岛素最小模型”(n=3311)从口服葡萄糖耐量试验中得出 HIC。通过磁共振波谱(n=1211)定量肝脂肪。采用已建立的单核苷酸多态性(SNP;115 个用于肝脂肪、155 个丙氨酸氨基转移酶、37 个胰岛素敏感性、37 个胰岛素分泌、72 个空腹胰岛素、5285 个 BMI、163 个内脏脂肪、270 个腰围、442 个甘油三酯、620 个高密度脂蛋白胆固醇、193 个 C 反应蛋白、53 个脂肪营养不良样表型)进行孟德尔随机化。

结果

HIC 与肝脂肪(p<0.003)和胰岛素敏感性(p<0.0001)呈负相关。肝脂肪和 HIC 均与胰岛素敏感性独立相关(p<0.0001)。孟德尔随机化(N=1054,N=2254;N=1985,N=2251)表明,肝脂肪和丙氨酸氨基转移酶均与 HIC 无因果关系。与 BMI 相关的 SNP 与 HIC 有因果关系(N=2772,N=2259,p<0.001),而腰围 SNP 则没有(N=2751,N=2280)。遗传决定的胰岛素敏感性与 HIC 无因果关系(N=2752,N=2286)。C 反应蛋白和高密度脂蛋白与 HIC 有因果关系,较高的 C 反应蛋白和较低的高密度脂蛋白导致较高的 HIC(N=2660,N=2240;N=2694,N=2275)。

结论

这项孟德尔随机化分析不支持肝脂肪与 HIC 之间存在因果关系。代谢综合征的其他成分似乎通过增加肝胰岛素提取来代偿外周性高胰岛素血症。

相似文献

1
Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.肝胰岛素清除的决定因素 - 孟德尔随机化研究的结果。
Metabolism. 2021 Jun;119:154776. doi: 10.1016/j.metabol.2021.154776. Epub 2021 Apr 20.
2
Hepatic insulin clearance is closely related to metabolic syndrome components.肝脏胰岛素清除率与代谢综合征各组分密切相关。
Diabetes Care. 2013 Nov;36(11):3779-85. doi: 10.2337/dc12-1203. Epub 2013 Sep 11.
3
Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.代谢相关脂肪性肝病的特征是,在代谢改变轻微的个体中,口服葡萄糖负荷后出现高胰岛素血症。
Am J Physiol Endocrinol Metab. 2024 May 1;326(5):E616-E625. doi: 10.1152/ajpendo.00294.2023. Epub 2024 Mar 13.
4
Blood Levels of the Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study.血清肝细胞素水平与 2 型糖尿病之间不存在因果关系:一项双向孟德尔随机化研究。
Nutrients. 2021 Nov 24;13(12):4208. doi: 10.3390/nu13124208.
5
Reduced insulin clearance in paediatric metabolic (dysfunction)-associated fatty liver disease and its dual role in beta-cell offload and diabetes risk.儿童代谢(功能)障碍相关脂肪性肝病中胰岛素清除减少及其在减轻β细胞负担和糖尿病风险中的双重作用。
Diabetes Obes Metab. 2024 Nov;26(11):5390-5398. doi: 10.1111/dom.15902. Epub 2024 Aug 27.
6
Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.南印度糖尿病前期受试者的遗传研究。高胰岛素血症和β细胞功能障碍的重要性。
Diabetes Care. 1998 Jan;21(1):76-9. doi: 10.2337/diacare.21.1.76.
7
Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.肝脏脂肪与β细胞功能或餐后游离脂肪酸反应无关。
Metabolism. 2009 Feb;58(2):196-203. doi: 10.1016/j.metabol.2008.09.013.
8
Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.2型糖尿病患者肝脏脂肪增加、胰岛素清除受损以及肝脏和脂肪组织胰岛素抵抗。
Gastroenterology. 2008 Jul;135(1):122-30. doi: 10.1053/j.gastro.2008.03.021. Epub 2008 Mar 21.
9
Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes.载脂蛋白样磷脂酶域蛋白 3 基因在糖尿病患者肝脏脂质含量和胰岛素抵抗中的作用。
Diabetes Care. 2020 Sep;43(9):2161-2168. doi: 10.2337/dc20-0329. Epub 2020 Jun 19.
10
Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.非酒精性脂肪性肝病、2 型糖尿病和肥胖之间的因果关系对疾病亚表型有影响。
J Hepatol. 2020 Aug;73(2):263-276. doi: 10.1016/j.jhep.2020.03.006. Epub 2020 Mar 10.

引用本文的文献

1
Insulin Clearance in Obesity and Type 2 Diabetes.肥胖与 2 型糖尿病患者的胰岛素清除率。
Int J Mol Sci. 2022 Jan 6;23(2):596. doi: 10.3390/ijms23020596.